Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 4:19AM ET - U.S. Markets open in 5 hours and 11 minutes. Dow Up 2.03% Nasdaq  0.00%
NexMed Inc. (NEXM)On Nov 9: 0.14   0.00 (0.00%)  
MORE ON NEXM
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
NexMed Inc.
89 Twin Rivers Drive
East Windsor, NJ 08520
United States - Map
Phone: 609-371-8123
Fax: 609-426-9116
Web Site: http://www.nexmed.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Full Time Employees:13

BUSINESS SUMMARY 
NexMed, Inc., a pharmaceutical and medical technology company, engages in the development of topical pharmaceutical products based on its proprietary NexACT transdermal drug delivery technology. The NexACT transdermal drug delivery technology is designed to enhance the absorption of an active drug through the skin and enable concentrations of the active drug to penetrate the desired site of the skin or extremity. The company’s products under development include NM100060, a topical nail solution for the treatment of onychomycosis; Vitaros, a topical alprostadil-based cream treatment for patients with erectile dysfunction; and Femprox, an alprostadil-based cream product for the treatment of female sexual arousal disorder. It also focuses on the development of topical treatments for psoriasis. The company has a licensing agreement with Novartis International Pharmaceutical Ltd. for the development, manufacture, and commercialization of NM100060. NexMed, Inc. was founded in 1987 and is based in East Windsor, New Jersey.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on NexMed Inc.


    CORPORATE GOVERNANCE 
    NexMed Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 63.5% of CGQ Universe companies and 39.2% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Ms. Vivian H. Liu , 47
    Chief Exec. Officer, Pres, Sec.
    N/A N/A
    Mr. Mark Westgate , 39
    Chief Financial Officer, Principal Accounting Officer, VP and Treasurer
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis